Investor enthusiasm for artificial intelligence stocks has propelled markets to new all-time highs in 2024. Unfortunately, the spectacular surge in a handful of leading AI technology stocks has also raised concerns among skeptics that the market could be overheating. AI technology could be one of the most transformative advances in economic history. While its true impact is only beginning to make a…
The long climb back to relevance continues for initial public offerings in the U.S. in 2024, as investors warm up to new publicly traded companies and IPOs are able to back that sentiment up with sturdier returns. So, where do IPOs go from here in the second half of 2024? Sustained high borrowing costs and suspense over a chaotic U.S.…
For a moment on June 18, the S&P 500 and Nasdaq-100 indexes had a new top holding: Nvidia Corp. (ticker: NVDA). Before paring back some gains later in the week, shares of Nvidia briefly surpassed $135 per share, giving the company a market capitalization of more than $3.3 trillion. That being said, retail investors may not find it prudent to…
ChatGPT and its creator, OpenAI, triggered the modern conversation around artificial intelligence. The AI large language model fascinated its users by providing relevant information based on text prompts. ChatGPT offers instant answers instead of requiring users to scan multiple pages on a search engine. Here are six stocks that either stand to benefit substantially from ChatGPT’s growth and the incorporation…
The S&P 500’s 2024 rally resumed in May as strong first-quarter earnings numbers overshadowed fears over slowing economic growth and potential stagflation. After a strong 2023 performance, the S&P 500 is up more than 10% year to date, and investors are hoping the inflation outlook will improve further in coming months. Top 2024 stock market performers include health care stocks with unique…
American retirees are gingerly making their way through their golden years, treading forward as all sorts of economic minefields surround them. Maybe that’s why 63% of Americans are more worried about running out of cash in retirement than dying, according to a new Allianz Life study. That’s where being disciplined and creative about low-risk but potentially high-return investments can help, even…
The global pharmaceutical industry will generate more than $1.16 trillion in sales in 2024, according to Statista. The oncology segment alone is expected to generate $214 billion in sales this year. The pharma industry is expected to grow 6.2% annually, reaching $1.47 trillion by 2028. Not only are pharmaceutical stocks excellent defensive investments in an uncertain economy, some pharma stocks…
Leaving money in a stagnant bank account guarantees that inflation will gradually reduce your purchasing power. Most bank savings rates don’t keep up with inflation, and even if they do, the interest payments get taxed as ordinary income. Investing in various assets can help investors beat inflation and reach their retirement goals sooner. Mutual funds and stocks are both useful starting points…
Stocks trading under $10 can be attractive for investors looking to scoop up some cheap shares. Unfortunately, quality stocks trading for less than $10 are few and far between. Stocks priced at this level can be a red flag for investors that something serious is wrong with a company. Many of these stocks have challenged underlying business models or difficult…
Federal Reserve Chairman Jerome Powell stuck to his script that it is not yet time to begin cutting interest rates on Wednesday in the first of two appearances this week on Capitol Hill. The Fed has taken interest levels to their highest in decades in a battle to bring inflation down to the central bank’s 2% annual target. Although significant progress has been made, prices remain…